Stay updated on Durvalumab & Olaparib in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab & Olaparib in Endometrial Cancer Clinical Trial page.

Latest updates to the Durvalumab & Olaparib in Endometrial Cancer Clinical Trial page
- Check6 days agoChange DetectedThe site update updates the revision from v3.5.2 to v3.5.3, indicating a deployment of a newer platform release. It does not describe any changes to the study data or page content.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded the JCO publication citation for the Phase III DUO-E trial with the full author list and DOI, including the Erratum. Updated the revision version from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check27 days agoChange DetectedDifference0.0%

- Check42 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

- Check56 days agoChange DetectedRevision: v3.4.3 has been added and Revision: v3.4.2 has been removed. No substantive changes to page content or functionality were detected.SummaryDifference0.0%

- Check84 days agoChange DetectedM.D. Anderson Cancer Center was added to the collaborators list and The University of Texas MD Anderson Cancer Center was removed, the government funding notice was deleted, and the page now shows Revision: v3.4.2.SummaryDifference0.2%

Stay in the know with updates to Durvalumab & Olaparib in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab & Olaparib in Endometrial Cancer Clinical Trial page.